The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Get the Facts on the Union Pacific Arbitration Award from SBA 1208!
- New Jersey Passes Two New Pro-Labor Laws Backed by SMART-TD
- VILP Enrollment Extended Through September 26!
- FRA Expands Bridge Safety Oversight
- Rep. Lawler’s Transit Funding Flexibility Act of 2025 receives SMART-TD Endorsement
- Join Railroaders from Across the Country for Houston Rail Labor Solidarity Rally!
- Registration Open for Atlanta Regional Training Seminar
- 2025 Labor Day Message from SMART-TD President Jeremy Ferguson
- Announcing the Winners of our 2025 Local Pride T-Shirt Contest!
- STATEMENT: SMART-TD Condemns Unprecedented Removal of STB Member Robert Primus